Actionable news
All posts from Actionable news
Actionable news in PFE: PFIZER Inc,

Pfizer Receives FDA Approval For Cheaper Version Of Johnson & Johnson's Top Drug Remicade

Trade with confidence. Are you a professional trader? Be the first to get the alert with Benzinga Pro's real-time newsfeed and audio squawk and never miss an opportunity again.
Don't miss the chance to try it FREE today.

Pfizer Inc. PFE 2.41% announced after Tuesday's market close that the U.S. Food and Drug Administration approved INFLECTRA, the first and only biosimilar monoclonal antibody therapy, and only the second biosimilar to be approved in the US.

INFLECTRA is a treatment indicated for reducing signs and symptoms in patients with rheumatoid arthritis, adult ulcerative colitis, plaque...